CrushSCI.com
106.8Average days
119Median days
23Fastest days
159Longest days
442025 publications

Paper Review Records

All Paper Review Records

6 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

114 days

Primary Breast Pure Metaplastic Squamous Cell Carcinoma: A Breast Abscess With Squamous Metaplasia and Malignant Transformation That Mimics Condylomata Acuminata

Authors
Jing Wen Loh; Ai Chen Chan; Abdul Kadir Rifaei Abd Rashid Khairi; Najihah Abu BakarShow moreShow less
Affiliations
1. Department of Surgery, Hospital Teluk Intan, Teluk Intan, Malaysia.; 2. Breast and Endocrine Surgery Unit, Department of Surgery, Hospital Raja Permaisuri Bainun, Ipoh, Malaysia.; 3. Department of Pathology, Hospital Teluk Intan, Teluk Intan, Malaysia.; 4. Department of Radiotherapy and Oncology, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia.Show moreShow less
Source PDF DOI Publisher page
159 days

Breast-Conserving Surgery After Neoadjuvant Chemotherapy Guided by a Supine Magnetic Resonance Imaging Projection Mapping System Visualizing Original Cancer Extent

Authors
Maki Amano; Jun Ozeki; Yumi Koyama; Mayumi Tani; Yuna Kaneko; Chisato Ando; Xiaoyan Tang; Fumi Nozaki; Yasuo Amano; Keiichiro TadaShow moreShow less
Affiliations
1. Department of Radiology, Nihon University Hospital, Tokyo, Japan.; 2. Department of Breast and Endocrine Surgery, Nihon University Hospital, Tokyo, Japan.; 3. Department of Diagnostic Radiology, Mitsui Memorial Hospital, Tokyo, Japan.; 4. Division of Radiological Technology, Nihon University Hospital, Tokyo, Japan.; 5. Department of Pathology, Nihon University Hospital, Tokyo, Japan.; 6. Department of Radiology, Nippon Medical School, Tokyo, Japan.; 7. Department of Breast and Endocrine Surgery, Nihon University Itabashi Hospital, Tokyo, Japan.Show moreShow less
Source PDF DOI Publisher page
80 days

α-Viniferin Induces Intrinsic Apoptosis in Triple-Negative Breast Cancer Cells and Synergizes With SB203580 Independently of p38 Mitogen-Activated Protein Kinase

Authors
Do-Gyeong Kim; Gyeongmi Kim; Ji Yea Kim; Se-Kyeong Jang; Hyunggee Kim; Hyeon-Ok Jin; Min-Ki Seong; Chan Sub Park; In-Chul Park; Hyun-Ah KimShow moreShow less
Affiliations
1. Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.; 2. Department of Biotechnology, College of Life Science and Biotechnology, Korea University, Seoul, Korea.; 3. Department of Ophthalmology & Visual Sciences, University of California, Irvine, CA, USA.; 4. KIRAMS Radiation Biobank, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.; 5. Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.Show moreShow less
Source PDF DOI Publisher page
124 days

Clinical Outcomes of Lobular Carcinoma In Situ : Risk of Invasive Cancer Development

Authors
Doyoun Woen; Ki Jo Kim; Su Min Lee; Seungah Lee; Kawon Oh; Cho Eun Lee; Seok Jin Nam; Seok Won Kim; Jeong Eon Lee; Byung Joo Chae; Se Kyung Lee; Jai Min Ryu; Woong Ki Park; Hyunwoo Lee; Jonghan YuShow moreShow less
Affiliations
1. Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.; 2. Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.Show moreShow less
Source PDF DOI Publisher page
23 days

Risk-Reducing Mastectomy in BRCA1/2 and Other High-Risk Gene Carriers: Current Evidence and Practical Guidance

Authors
Jun-Hee Lee; Jai Min Ryu; Ji Soo Park; Joo Heung Kim; Chihwan David Cha; Kyung Jin Eoh; Yaewon Yang; Bom-Yi Lee; Sang-Ah Han; Sung-Won KimShow moreShow less
Affiliations
1. Department of Surgery, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.; 2. Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.; 3. Hereditary Cancer Clinic of Cancer Prevention Center, Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.; 4. Department of Surgery, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.; 5. Department of Surgery, Hanyang University Hospital, Hanyang University College of Medicine, Seoul, Korea.; 6. Department of Obstetrics and Gynecology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.; 7. Department of Internal Medicine, Chungbuk University Hospital, Chungbuk University College of Medicine, Cheongju, Korea.; 8. Breast Care Center, Breast Cancer Hospital, Daerim St. Mary’s Hospital, Seoul, Korea.; 9. Department of Surgery, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul, Korea.; 10. Department of Surgery, Breast Care Center, Breast Cancer Hospital, Daerim St. Mary’s Hospital, Seoul, Korea.Show moreShow less
Source PDF DOI Publisher page
141 days

Long-term Outcomes of Slowly Proliferating Luminal A-like Invasive Lobular Carcinoma Versus Invasive Carcinoma of No Special Type

Authors
Dahn Byun; Ji Won Yoo; Jihoon Lee; Ki Beom Kim; Ki Jo Kim; Seungah Lee; Doyoun Woen; Su Min Lee; Kawon Oh; Cho Eun Lee; Woong Ki Park; Jai Min Ryu; Se Kyung Lee; Byung Joo Chae; Jonghan Yu; Seok Won Kim; Seok Jin Nam; Jeong Eon LeeShow moreShow less
Affiliations
1. Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.Show moreShow less
Source PDF DOI Publisher page

FAQ

How long does Journal of Breast Cancer take to review a manuscript?

As of 2026-11-19, CrushSCI has 6 complete review records for Journal of Breast Cancer. The fastest paper went from submission to acceptance in 23 days (Risk-Reducing Mastectomy in BRCA1/2 and Other High-Risk Gene Carriers: Current Evidence and Practical Guidance, received 2025-11-09, accepted 2025-12-02); the slowest took 159 days. The average is 106.8 days and the median is 119 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.